Mechanisms underlying the antiarrhythmic effect of ARumenamide-787 in experimental models of the J wave syndromes and hypothermia
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0281977 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von José M Di Diego und 9 weiteren Autor:innen. Beteiligte Einrichtung: Lankenau Institute for Medical Research, Wynnewood, PA, United States of America. Hauptthemen laut MEDLINE: Hypothermia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, W. W. Smith Charitable Trust.
Abstract (Originalsprache)
Background
Brugada (BrS) and early repolarization syndromes (ERS), the so-called J wave syndromes (JWS), are associated with life-threatening ventricular arrhythmias. Pharmacologic approaches to therapy are currently limited. In this study, we examine the effects of ARumenamide-787 (AR-787) to suppress the electrocardiographic and arrhythmic manifestations of JWS and hypothermia.
Methods
We studied the effects of AR-787 on I Na and I Kr in HEK-293 cells stably expressing the α- and β1-subunits of the cardiac (Na V 1.5) sodium channel and hERG channel, respectively. In addition, we studied its effect on I to , I Na and I Ca in dissociated canine ventricular myocytes along with action potentials and ECG from coronary-perfused right (RV) and left (LV) ventricular wedge preparations. The I to agonist, NS5806 (5–10 μM), I Ca blocker, verapamil (2.5 μM), and I Na blocker, ajmaline (2.5 μM), were used to mimic the genetic defects associated with JWS and to induce the electrocardiographic and arrhythmic manifestations of JWS (prominent J waves/ST segment elevation, phase 2 reentry and polymorphic VT/VF) in canine ventricular wedge preparations.
Results
AR-787 (1, 10 and 50 μM) exerted pleiotropic effects on cardiac ion channels. The predominant effect was inhibition of the transient outward current (I to ) and enhancement of the sodium channel current (I Na ), with lesser effects to inhibit I Kr and augment calcium channel current (I Ca ). AR-787 diminished the electrocardiographic J wave and prevented and/or suppressed all arrhythmic activity in canine RV and LV experimental models of BrS, ERS and hypothermia.
Conclusions
Our findings point to AR-787 as promising candidate for the pharmacologic treatment of JWS and hypothermia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lankenau Institute for Medical Research, Wynnewood, PA, United States of America.
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States of America.
- Simon Fraser University, Burnaby, BC, Canada.
- Lankenau Heart Institute, Wynnewood, PA, United States of America.
ORCID-Profile: Peter C Ruben, Charles Antzelevitch
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- W. W. Smith Charitable Trust
- Wistar and Martha Morris Fund.
- Sharpe Strumia Research Foundation
Zitieren
APA
Di Diego, J. M., Barajas-Martinez, H., Cox, R., Robinson, V. M., Jung, J., Fouda, M., Patocskai, B., Abdelsayed, M., Ruben, P. C., & Antzelevitch, C. (2023). Mechanisms underlying the antiarrhythmic effect of ARumenamide-787 in experimental models of the J wave syndromes and hypothermia. PLOS ONE. https://doi.org/10.1371/journal.pone.0281977
Vancouver
Di Diego JM, Barajas-Martinez H, Cox R, Robinson VM, Jung J, Fouda M, et al. Mechanisms underlying the antiarrhythmic effect of ARumenamide-787 in experimental models of the J wave syndromes and hypothermia. PLOS ONE. 2023. doi:10.1371/journal.pone.0281977
BibTeX
@article{DiDiego2023,
author = {Di Diego, José M and Barajas-Martinez, Hector and Cox, Robert and Robinson, Victoria M and Jung, Joseph and Fouda, Mohamed and Patocskai, Bence and Abdelsayed, Mena and Ruben, Peter C and Antzelevitch, Charles},
title = {Mechanisms underlying the antiarrhythmic effect of ARumenamide-787 in experimental models of the J wave syndromes and hypothermia},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0281977}
}
EUVIMED